4
Changes in Ownership
BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-18-010694
Senior VP - Drug Discovery gave up 21,125 shares (to pay taxes)
- Senior VP - Drug Discovery acquired 30,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Babu Yarlagadda S · Senior VP - Drug Discovery
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-03-06 | Exercise or conversion : show line 1 in the form | +20,622 | $3.26 | $67,228 | 120,618 | D |
| 2018-03-06 | Shares withheld for taxes : show line 2 in the form | −15,223 | $5.18 | $78,855 | 105,395 | D |
| 2018-03-06 | Exercise or conversion : show line 3 in the form | +9,378 | $3.26 | $30,572 | 114,773 | D |
| 2018-03-06 | Shares withheld for taxes : show line 4 in the form | −5,902 | $5.18 | $30,572 | 108,871 | D |
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2018-03-06 | Exercise or conversion : show line 5 in the form Non-Qualified Stock Option | −20,622 | 0 | D |
| 2018-03-06 | Exercise or conversion : show line 6 in the form Emp. Stock Option (Right to Buy) | −9,378 | 0 | D |
Loading xslF345X03/form4.xml…